Prosecution Insights
Last updated: October 02, 2026

Examiner: THOMPSON, MILANA KAYE

Tech Center 2100 • Art Units: 1685 1687 2147

This examiner grants 0% of resolved cases

Analysis

Milana Kaye Thompson is an examiner in Tech Center 2100 and Art Unit 1685. The examiner has an allowance rate of 0.0% based on 4 resolved cases. The median days to allowance is 1522. This sample size and the 0.0% allowance rate provide an initial look at the examiner's results. The 1522-day timeline is a metric for the duration of cases assigned to this unit.

The interview lift is currently 0.0%. Because none of the 4 resolved cases have resulted in an allowance, the data does not yet show a statistical benefit to conducting interviews. Practitioners should monitor these metrics as the examiner's case volume grows beyond 4. For now, the 0.0% allowance rate and 1522-day median pendency suggest that applicants should be prepared for the prosecution process. The 0.0% rate indicates that cases resolved so far have not reached a grant. Success in Art Unit 1685 with this examiner may require a specific approach based on these early figures.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

0.0%
Allow Rate
-55.0% vs TC avg
22
Total Applications
+0.0%
Interview Lift
1522
Avg Prosecution Days
Based on 4 resolved cases, 2023–2026

Rejection Statute Breakdown

8.7%
§101 Eligibility
15.1%
§102 Novelty
51.6%
§103 Obviousness
15.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17830202 STATE LEARNING IN AN EVENT-SOURCED ARCHITECTURE FOR MATERIALS PROVENANCE (ESAMP) Non-Final OA TOYOTA RESEARCH INSTITUTE, INC.
18025394 METHOD AND APPARATUS FOR PREDICTING RNA-PROTEIN INTERACTION, MEDIUM AND ELECTRONIC DEVICE Non-Final OA BOE Technology Group Co., Ltd.
17947820 USE OF GENETIC ALGORITHMS TO DETERMINE A MODEL TO IDENTITY SAMPLE PROPERTIES BASED ON RAMAN SPECTRA Final Rejection GENENTECH, INC.
18099910 CLASSIFIER FOR IDENTIFICATION OF ROBUST SEPSIS SUBTYPES Non-Final OA The Board of Trustees of the Leland Stanford Junior University
18096155 SIGNAL PROCESSING APPARATUS, SIGNAL PROCESSING METHOD, AND NON-TRANSITORY COMPUTER READABLE MEDIUM Non-Final OA Hitachi, Ltd.
18449748 DISENTANGLED WASSERSTEIN AUTOENCODER FOR PROTEIN ENGINEERING Non-Final OA NEC Laboratories America, Inc.
17759838 Conformal Inference for Optimization Non-Final OA Flagship Pioneering Innovations VI, LLC
18088777 CLOSE-LOOP DEEP BRAIN STIMULATION ALGORITHM SYSTEM FOR PARKINSON?S DISEASE AND CLOSE-LOOP DEEP BRAIN STIMULATION ALGORITHM METHOD FOR PARKINSON?S DISEASE Non-Final OA Industrial Technology Research Institute
18140583 IN SILICO PREDICTIONS OF AMYLOID-RELATED IMAGING ABNORMALITIES Non-Final OA HOFFMANN-LA ROCHE INC.
17792284 ERROR SUPPRESSION IN GENETIC SEQUENCING Final Rejection St. Jude Children's Research Hospital

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month